ANI Pharmaceuticals Inc (ANIP)
61.43
-2.34
(-3.67%)
USD |
NASDAQ |
May 17, 16:00
61.45
+0.02
(+0.03%)
After-Hours: 20:00
ANI Pharmaceuticals Research and Development Expense (Annual): 34.29M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.29M |
| December 31, 2022 | 22.32M |
| December 31, 2021 | 11.37M |
| December 31, 2020 | 16.00M |
| December 31, 2019 | 19.81M |
| December 31, 2018 | 15.39M |
| December 31, 2017 | 9.07M |
| December 31, 2016 | 2.906M |
| December 31, 2015 | 2.874M |
| December 31, 2014 | 2.678M |
| December 31, 2013 | 1.712M |
| December 31, 2012 | 16.89M |
| December 31, 2011 | 44.18M |
| Date | Value |
|---|---|
| December 31, 2010 | 39.71M |
| December 31, 2009 | 13.68M |
| December 31, 2008 | 15.79M |
| December 31, 2007 | 4.751M |
| December 31, 2006 | 3.856M |
| December 31, 2005 | 6.409M |
| December 31, 2004 | 9.162M |
| December 31, 2003 | 3.691M |
| December 31, 2002 | 4.787M |
| December 31, 2001 | 2.142M |
| December 31, 2000 | 1.888M |
| December 31, 1999 | 0.6606M |
| December 31, 1998 | 1.400M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
11.37M
Minimum
2021
34.29M
Maximum
2023
20.76M
Average
19.81M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Ligand Pharmaceuticals Inc | 24.54M |
| ADMA Biologics Inc | 3.30M |
| Annovis Bio Inc | 38.79M |
| United Therapeutics Corp | 408.00M |
| Allogene Therapeutics Inc | 242.91M |